Evidence map›Paper›PMID 39619422›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2024

Efficacy of nutritional support in combination with standard Buruli ulcer treatment: A case study in Côte d'Ivoire.

Yao Didier Koffi, Paul Aboa Koffi, Evans Ehouman, Saint-Pierre Kouadio, Mamadou Kaloga

Abstract read
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Buruli ulcer: Current landscape, challenges, and future directions.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yao Didier KoffiNational Buruli Control Program Abidjan, Cote d'Ivoire.
Paul Aboa KoffiNational Buruli Control Program Abidjan, Cote d'Ivoire.
Evans EhoumanCentre de Coopération Internationale en Recherche Agronomique Pour le Développement (CIRAD), Abidjan, Cote d'Ivoire.
Saint-Pierre KouadioNational Polytechnic Institute Houphouët-Boigny, Yamoussoukro, Cote d'Ivoire.
Mamadou KalogaNational Buruli Control Program Abidjan, Cote d'Ivoire.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Buruli ulcer (BU) is an infectious skin disease caused by Method: This was a prospective, randomized, single-blind paired interventional study conducted in BU-endemic health districts of Côte d'Ivoire. This 12-month study had two arms: the standard protocol versus the test treatment (SPSRM-1). SRM-1 is a cereal-based nutraceutical composed of 60 % cereal, 25 % vegetable, and 15 % plant concentrate. Patients included in the study had uncomplicated category I and II ulcerations without comorbidities. Nutritional status including haemoglobin, albumin levels, and body mass index (BMI) was evaluated from enrolment to the end of the study, alongside ulcer healing rates. Results: Sixty BU wound patients were enrolled: 30 in the control group and 30 in the test group, with a mean age of 22 years. Of the patients, 28.3 % were malnourished, and 42 % had hypoalbuminemia. At the primary endpoint, 6 patients (20.0 %) in the SPSRM1 and 5 patients (16.7 %) in the SP group achieved complete epithelialization, with a reduction rate of 0.7 % per day in the SPSRM1 group compared to 0.3 % per day in the SP group. Patients who received SRM-1 had a higher BMI than those who did not, with a mean difference of 1.72 kg/m Conclusion: This study demonstrated the potential benefit of adding nutritional support to improve BU treatment outcomes, by shortening the healing time of ulcerations. However, further studies with larger sample sizes are necessary to confirm these findings.

Indexed as

Buruli ulcerCôte d’IvoireHealing rateNutritional statusStandard protocol

Identifiers

PMID39619422
PMCPMC11607664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.